Similar articles

• TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.

  't Hoen E. 't Hoen E. Chic J Int Law. 2002 Spring;3(1):27-46. Chic J Int Law. 2002. PMID: 15709298 No abstract available.
• The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.

  Curti AM. Curti AM. Am J Law Med. 2001;27(4):469-85. Am J Law Med. 2001. PMID: 11837145 No abstract available.
• Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.

  Berger JM. Berger JM. Conn J Int Law. 2002 Spring;17(2):157-248. Conn J Int Law. 2002. PMID: 12688292 No abstract available.
• TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.

  Orsi F, D'Almeida C, Hasenclever L, Camara M, Tigre P, Coriat B. Orsi F, et al. AIDS. 2007 Oct 1;21(15):1997-2003. doi: 10.1097/QAD.0b013e328273bbe4. AIDS. 2007. PMID: 17885289 Review. No abstract available.
• Can (and should) Africa make its own medicines?

  Kardas-Nelson M. Kardas-Nelson M. BMJ. 2015 Apr 28;350:h2178. doi: 10.1136/bmj.h2178. BMJ. 2015. PMID: 25920478 Review. No abstract available.